BioSpace News Archive

This analysis investigates CLI patients, who despite a successful procedure, do not respond to endovascular and surgical revascularization.

Chosen among thousands of companies appearing at CES® this year, Engadget awarded Olive Union’s Smart Ear “Best Wearable” in the International CES 2020 “Best of CES Awards” based on innovation, quality of design, overall efficiency and market demand.

With the potential to cause up to 90 percent annual yield loss, nematodes can be a key threat to a potato crop.

Movement Industries Corporation announced the creation of its new South Texas Sales Division set to officially open January 20, 2020.

SparingVision, a biotechnology company innovating treatment of blinding inherited retinal diseases such as Retinitis Pigmentosa and pioneer in the development of a gene-independent treatment for retinitis pigmentosa, attends the Biotech Showcase in San Francisco to meet with investors and strategic partners.

First stage clinical efficacy endpoint met for the Phase II trial cohort evaluating selective AXL inhibitor bemcentinib in combination with Keytruda® in patients with advanced NSCLC who have failed checkpoint inhibitor therapy

Barrett will facilitate continued growth and collaboration with teams dedicated to delivering a world-class customer experience.

New requirements of the Safe Food for Canadians Regulations come into force for most businesses in the fresh fruits or vegetables sector that import, export or engage in interprovincial trade.

Crescendo Biologics Ltd, the drug developer of novel, targeted, T cell enhancing therapeutics, announces the publication of a paper that demonstrates greater tissue penetration and in vivo efficacy of Humabody® VH therapeutics compared to conventional antibody formats, in the scientific journal Cancer Research a journal of the American Association for Cancer Research.

Zhittya believes its new therapy could be considered a “disease modifying agent” with the potential to reduce and possibly even reverse the inexorable decline seen in patients who suffer from this devastating disease.